Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Federal Trade Commission
Chinese Patent Office
Moodys
Boehringer Ingelheim
Cipla
US Department of Justice
Dow

Generated: May 21, 2018

DrugPatentWatch Database Preview

RESERPINE AND HYDROFLUMETHIAZIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Reserpine And Hydroflumethiazide patents expire, and what generic alternatives are available?

Reserpine And Hydroflumethiazide is a drug marketed by Ivax Pharms and Par Pharm and is included in two NDAs.

The generic ingredient in RESERPINE AND HYDROFLUMETHIAZIDE is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
Summary for RESERPINE AND HYDROFLUMETHIAZIDE
Drug patent expirations by year for RESERPINE AND HYDROFLUMETHIAZIDE

US Patents and Regulatory Information for RESERPINE AND HYDROFLUMETHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Pharms RESERPINE AND HYDROFLUMETHIAZIDE hydroflumethiazide; reserpine TABLET;ORAL 088932-001 Jan 11, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm RESERPINE AND HYDROFLUMETHIAZIDE hydroflumethiazide; reserpine TABLET;ORAL 088907-001 Sep 20, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Accenture
Julphar
Queensland Health
Covington
Chubb
Harvard Business School
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.